# Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome

> **NCT01200732** · PHASE2 · COMPLETED · sponsor: **Govind Ballabh Pant Hospital** · enrollment: 28 (actual)

## Conditions studied

- Eisenmenger Syndrome

## Interventions

- **DRUG:** Tadalafil, placebo

## Key facts

- **NCT ID:** NCT01200732
- **Lead sponsor:** Govind Ballabh Pant Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2010-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01200732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01200732, "Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01200732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*